| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 26.08× | 26.08× | 27.40× | 36.82× | 57.17× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.25× | 0.25× | 0.35× | 0.41× | 0.41× | ||
| −4.53× | −4.53× | −1.59× | −0.29× | 0.90× | ||
| −2.28× | −2.28× | −0.94× | −0.20× | 0.62× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 57.17 | 36.82 | 27.40 | 26.08 | 26.08 | |
| Asset Turnover | 0.41 | 0.41 | 0.35 | 0.25 | 0.25 | |
| Cash Conversion (CFO/Net Income) | 0.90 | -0.29 | -1.59 | -4.53 | -4.53 | |
| CFO/EBITDA | 0.62 | -0.20 | -0.94 | -2.28 | -2.28 |